Entact Bio
Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed to create enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
Tech Stack (1 technologies)
Frequently Asked Questions
What technologies does Entact Bio use?+
Entact Bio uses 1 technologies including Nginx.
What industry is Entact Bio in?+
Entact Bio operates in the Biopharma industry.
Where is Entact Bio based?+
Entact Bio is headquartered in United States.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026